News & Events - Inventiva Pharma

News & Events

Inventiva to participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference

24 November 2020

Q3 2020 Financial Information

12 November 2020

Inventiva receives positive FDA feedback to advance its lead drug candidate lanifibranor into pivotal Phase III in NASH

10 November 2020

Inventiva to participate at the Stifel Virtual Healthcare Conference 2020 and the 11th Jefferies Virtual Healthcare Conference

9 November 2020

Inventiva announces the appointment of Dr. Michael Cooreman as Chief Medical Officer

5 November 2020

Inventiva announces the publication of a scientific paper on the role of PPARs in the treatment of NASH in the medical journal Nature Review Gastroenterology & Hepatology

2 November 2020

Inventiva announces the additional acceptance of two late-breaking abstracts at the AASLD The Liver Meeting Digital Experience™ 2020

2 November 2020

Inventiva to host a Key Opinion Leader webcast from the AASLD The Liver Meeting Digital Experience™ 2020

28 October 2020

Inventiva receives FDA Fast Track designation in MPS VI for its clinical-stage asset odiparcil

19 October 2020

Load More

Upcoming Investors Meetings

Upcoming Science Conferences

Questions?
Get in touch!

Inventiva
Frédéric Cren
Chief Executive Officer
info@inventivapharma.com
+33 3 80 44 75 00

Brunswick
Yannick Tetzlaff / Tristan Roquet Montegon / Aude Lepreux
Media relations
inventiva@brunswickgroup.com
+33 1 53 96 83 83

Patti Bank
Managing Director
ICR Westwicke
Patti.Bank@westwicke.com
D 415-513-1284
San Francisco, CA
www.westwicke.com

News & Events